Provided by Tiger Trade Technology Pte. Ltd.

Trevi Therapeutics, Inc.

15.91
-0.7300-4.39%
Pre-market: 15.84-0.0688-0.43%04:54 EDT
Volume:1.25M
Turnover:19.92M
Market Cap:2.26B
PE:-45.22
High:16.51
Open:16.51
Low:15.71
Close:16.64
52wk High:20.22
52wk Low:7.65
Shares:142.00M
Float Shares:118.00M
Volume Ratio:1.03
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3518
EPS(LYR):-0.3173
ROE:-19.66%
ROA:-13.82%
PB:7.03
PE(LYR):-50.14

Loading ...

Trevi Therapeutics Launches Common Stock Offering

MT Newswires Live
·
Apr 17

BRIEF-Trevi Therapeutics Announces Proposed Public Offering Of Common Stock

Reuters
·
Apr 17

Trevi Therapeutics Shares Down 5.6% After the Bell; Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Apr 17

Trevi Therapeutics launches USD 150 million underwritten common stock offering

Reuters
·
Apr 17

Trevi Therapeutics Inc - Commences $150 Mln Underwritten Public Offering of Common Stock

THOMSON REUTERS
·
Apr 17

Press Release: Trevi Therapeutics Announces Proposed Public Offering of Common Stock

Dow Jones
·
Apr 17

Trevi Therapeutics (TRVI) Is Up 10.5% After Seeking Major Share Increase For Added Strategic Flexibility

Simply Wall St.
·
Apr 12

Trevi Therapeutics announces annual shareholder meeting plans

Reuters
·
Apr 11

Trevi Therapeutics to host investor and analyst day, join healthcare conferences

Reuters
·
Apr 01

Analysts Conflicted on These Healthcare Names: Trevi Therapeutics (TRVI), Annexon Biosciences (ANNX) and Medtronic (MDT)

TIPRANKS
·
Mar 19

Stock Track | Trevi Therapeutics Plummets 5% Intraday After Morgan Stanley Cuts Target Price

Stock Track
·
Mar 19

Stock Track | Trevi Therapeutics Soars 7.15% in Pre-Market on Positive Analyst Coverage

Stock Track
·
Mar 18

Trevi Therapeutics Inc : Morgan Stanley Cuts Target Price to $18.00 From $19.00

THOMSON REUTERS
·
Mar 18

Trevi Therapeutics (TRVI) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Mar 18

Trevi Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 18

Earnings Flash (TRVI) Trevi Therapeutics Posts Q4 Loss $-0.06, vs. FactSet Est of Loss of $-0.10

MT Newswires Live
·
Mar 18

Trevi Therapeutics Q4 net loss narrows 27.13% to USD 8.32 million

Reuters
·
Mar 18

BRIEF-Trevi Therapeutics Q4 Net Income USD -8.316 Million

Reuters
·
Mar 18

Trevi Therapeutics Q4 Operating Expenses USD 10.22 Million

THOMSON REUTERS
·
Mar 18

Press Release: Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 18